Eif2Ak3 Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Eif2Ak3 Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3 | |
|---|---|
| Gene Symbol | EIF2AK3 |
| Full Name | Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3 |
| Chromosome | 2p22.2 |
| NCBI Gene ID | 9451 |
| OMIM | 604032 |
| Ensembl ID | ENSG00000168269 |
| UniProt ID | Q9BXJ6 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, Wolcott-Rallison Syndrome |
EIF2AK3 (also known as PERK or EIF2AK1) is an ER transmembrane kinase that initiates the integrated stress response (ISR). It phosphorylates eIF2α to reduce protein translation during ER stress[^1].
EIF2AK3/PERK is one of three ER stress sensors:
EIF2AK3/PERK performs critical stress response functions:
EIF2AK3/PERK is implicated in AD:
In PD:
In ALS:
EIF2AK3 mutations cause WRS:
EIF2AK3 is expressed in:
In the brain, EIF2AK3 is expressed in neurons and glia, with activation in response to ER stress.
Harding HP, et al. (2000). "Perk is essential for translational regulation and cell survival during the unfolded protein response." Mol Cell. 5(5):897-904.[^1]
Moreno JA, et al. (2012). "Sustained translational repression by eIF2α-P mediates prion neurodegeneration." Nature. 485(7399):507-511.[^2]
Eif2Ak3 Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Eif2Ak3 Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.